This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Amyloid precursor protein
From Proteopedia
| Line 1: | Line 1: | ||
| - | + | {{STRUCTURE_1mwp| PDB=1mwp | SIZE=400| SCENE= |right| CAPTION=Human amyloid precursor protein heparin-binding domain [[1mwp]] }} | |
| - | '''Amyloid precursor protein''' (APP) is thought to regulate transcription. APP is cleaved by β-secretase and the resulting N terminal peptide which is ca. 40 amino acid long is called hAPP β-peptide. | + | == Function == |
| + | |||
| + | '''Amyloid precursor protein''' (APP) is a transmembranal protein which is thought to regulate transcription. APP plays a role in synaptic formation and repair. | ||
| + | |||
| + | == Disease == | ||
| + | |||
| + | APP is cleaved by β-secretase and the resulting N terminal peptide which is ca. 40 amino acid long is called hAPP β-peptide. The aggregation of the hAPP β-peptide is the cause of Alzheimer’s Disease. For detailed discussion see<br /> | ||
* [[Human APP]]<br /> | * [[Human APP]]<br /> | ||
* [[Human APP Intracellular Domain Complex with Fe65-PTB2]]<br /> | * [[Human APP Intracellular Domain Complex with Fe65-PTB2]]<br /> | ||
* [[Amyloid beta]]. | * [[Amyloid beta]]. | ||
| - | + | == Structural highlights == | |
| + | |||
| + | The extracellular region of APP contains several domains named E1 (residues 1-189) and E2 (residues 346-551). The E1 domain contains a growth factor-like or heparin-binding (residues 28-123) and Cu-binding (residues 124-189) subdomains. Additional domains are: Kunitz-type protease inhibitor (residues 287-344) and Zn-binding (residues 672-687). The Z-binding domain is involved in the oligomerizatin of APP. | ||
==3D structures of amyloid precursor protein== | ==3D structures of amyloid precursor protein== | ||
| Line 22: | Line 30: | ||
**[[1rw6]] - hAPP residues 346-551<BR /> | **[[1rw6]] - hAPP residues 346-551<BR /> | ||
**[[1tkn]] - hAPP residues 460-569 - NMR<BR /> | **[[1tkn]] - hAPP residues 460-569 - NMR<BR /> | ||
| - | **[[1qyt]], [[1qwp]], [[1qxc]] - hAPP residues 25-35 – NMR<BR /> | ||
**[[1mwp]] - hAPP heparin-binding domain<br /> | **[[1mwp]] - hAPP heparin-binding domain<br /> | ||
| Line 29: | Line 36: | ||
**[[1z0q]], [[2beg]] – hAPP β-peptide residues 1-42 – NMR<br /> | **[[1z0q]], [[2beg]] – hAPP β-peptide residues 1-42 – NMR<br /> | ||
**[[1amb]], [[1amc]] – hAPP β-peptide residues 1-28 – NMR<br /> | **[[1amb]], [[1amc]] – hAPP β-peptide residues 1-28 – NMR<br /> | ||
| - | **[[1qcm]], [[ | + | **[[1qcm]], [[1qyt]], [[1qwp]], [[1qxc]] – hAPP β-peptide residues 25-35 – NMR<br /> |
**[[1ba4]], [[1ba6]], [[2lnq]] – hAPP β-peptide residues 1-40 – NMR<br /> | **[[1ba4]], [[1ba6]], [[2lnq]] – hAPP β-peptide residues 1-40 – NMR<br /> | ||
**[[1bjb]], [[1bjc]] – hAPP β-peptide residues 1-28 (mutant) – NMR<br /> | **[[1bjb]], [[1bjc]] – hAPP β-peptide residues 1-28 (mutant) – NMR<br /> | ||
| Line 42: | Line 49: | ||
**[[1ze9]] - hAPP zinc-binding domain + Zn – NMR<BR /> | **[[1ze9]] - hAPP zinc-binding domain + Zn – NMR<BR /> | ||
**[[2fk1]], [[2fk2]], [[2fk3]], [[2fkl]] - hAPP residues 133-189 + Cu<BR /> | **[[2fk1]], [[2fk2]], [[2fk3]], [[2fkl]] - hAPP residues 133-189 + Cu<BR /> | ||
| - | **[[3jti]], [[3gci]] – hAPP peptide + phospholipase A2<BR /> | + | **[[3jti]], [[3gci]] – hAPP peptide residues 699-706 + phospholipase A2<BR /> |
| - | **[[3l81]] - hAPP peptide + AP-4 complex subunit μ-1<BR /> | + | **[[3l81]] - hAPP peptide residues 761-767 + AP-4 complex subunit μ-1<BR /> |
| - | **[[3ifl]], [[3ifn]], [[3ifo]], [[3ifp]], [[2r0w]] - hAPP peptide + antibody<BR /> | + | **[[3ifl]], [[3ifn]], [[3ifo]], [[3ifp]], [[2r0w]] - hAPP peptide residues 672-711 + antibody<BR /> |
| - | **[[2wk3]] - hAPP residues | + | **[[2wk3]] - hAPP residues 672-713 + insulin degrading enzyme<BR /> |
**[[3dxc]] - hAPP residues 739-770 + Fe65-PTB2<BR /> | **[[3dxc]] - hAPP residues 739-770 + Fe65-PTB2<BR /> | ||
**[[3dxd]], [[3dxe]] - hAPP residues 739-770 (mutant) + Fe65-PTB2<BR /> | **[[3dxd]], [[3dxe]] - hAPP residues 739-770 (mutant) + Fe65-PTB2<BR /> | ||
| - | **[[2roz]] - hAPP peptide + Fe65 C terminal<BR /> | + | **[[2roz]] - hAPP peptide residues 582-704 + Fe65 C terminal<BR /> |
**[[2otk]] - hAPP residues 672-711 + ZAB3 affibody dimer - NMR<BR /> | **[[2otk]] - hAPP residues 672-711 + ZAB3 affibody dimer - NMR<BR /> | ||
**[[3l3t]] - hAPP residues 211-267 + mesotrypsin<br /> | **[[3l3t]] - hAPP residues 211-267 + mesotrypsin<br /> | ||
Revision as of 11:04, 1 November 2015
| |||||||||
| Human amyloid precursor protein heparin-binding domain 1mwp | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| |||||||||
| |||||||||
| Resources: | FirstGlance, OCA, RCSB, PDBsum | ||||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||||
Contents |
Function
Amyloid precursor protein (APP) is a transmembranal protein which is thought to regulate transcription. APP plays a role in synaptic formation and repair.
Disease
APP is cleaved by β-secretase and the resulting N terminal peptide which is ca. 40 amino acid long is called hAPP β-peptide. The aggregation of the hAPP β-peptide is the cause of Alzheimer’s Disease. For detailed discussion see
Structural highlights
The extracellular region of APP contains several domains named E1 (residues 1-189) and E2 (residues 346-551). The E1 domain contains a growth factor-like or heparin-binding (residues 28-123) and Cu-binding (residues 124-189) subdomains. Additional domains are: Kunitz-type protease inhibitor (residues 287-344) and Zn-binding (residues 672-687). The Z-binding domain is involved in the oligomerizatin of APP.
3D structures of amyloid precursor protein
Updated on 01-November-2015


